Have any questions?

Zarqa’s Epilepsy Panel

“Unraveling the Complexity of Seizure Disorders”

Overview

Epilepsy encompasses a spectrum of seizure disorders, each presenting unique challenges in diagnosis and management. Zarqa’s Epilepsy Panel offers a comprehensive approach, targeting various seizure syndromes and associated genetic factors to provide accurate diagnoses and tailored treatment strategies.

Key Features:

Phenotype-Directed Testing

Our panel is designed to cover different types of seizure syndromes, including Dravet syndrome, early infantile epileptic encephalopathy, myoclonic epilepsy, and more.

Comprehensive Coverage

With 783 genes analyzed, including mitochondrial and nuclear mitochondrial genes, our panel ensures thorough examination of genetic factors contributing to epilepsy and related disorders.

Cutting-edge Technology

Utilizing Next-Generation Sequencing (NGS) with CNV analysis and repeat expansion analysis for precise and reliable results.

Fast Turnaround

Results delivered within 30 business days, enabling timely diagnosis and intervention for patients.

Common Syndromes Covered

  • Aicardi-Goutieres syndrome
  • Brain iron accumulation syndromes
  • Dravet syndrome
  • Early infantile epileptic encephalopathy
  • Epilepsy (absence) in childhood
  • Epilepsy (generalized) with febrile seizures
  • Epilepsy (partial)
  • Epileptic encephalopathy
  • Myoclonic epilepsy
  • Hypomagnesemia
  • Leigh syndrome
  • Mitochondrial encephalomyopathy
  • Muscular dystrophy-dystroglycanopathy
  • Urea cycle disorder

And more…

Sample Requirements:

  • Blood
  • Saliva
  • DBS
  • Tasso Kits

Coverage:

  • ≥99.00% ≥20x